0
0
0
A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.
12/30/2022, 4:04 AM
Congressional Summary of S 3489
This bill directs the National Institutes of Health (NIH) to support research on medical products for virus families and viral pathogens with pandemic potential.
Specifically, the NIH must establish or continue a multidisciplinary program for supporting research centers to advance the discovery and development of medical products to prevent, treat, and diagnose such viruses.
Read the Full Bill
Current Status of Bill S 3489
Bill S 3489 is currently in the status of Bill Introduced since January 12, 2022. Bill S 3489 was introduced during Congress 117 and was introduced to the Senate on January 12, 2022. Bill S 3489's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of January 12, 2022
Bipartisan Support of Bill S 3489
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
1Democrat Cosponsors
1Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 3489
Primary Policy Focus
HealthPotential Impact Areas
- Chemical and biological weapons
- Department of Health and Human Services
- Drug therapy
- Emergency medical services and trauma care
- Hazardous wastes and toxic substances
- Health programs administration and funding
- Health promotion and preventive care
- Health technology, devices, supplies
- Home and outpatient care
- Infectious and parasitic diseases
- Medical research
- Medical tests and diagnostic methods
- National Institutes of Health (NIH)
- Nuclear weapons
- Product development and innovation
- Research administration and funding
- Research and development
- Scientific communication
Alternate Title(s) of Bill S 3489
A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.
A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.
Comments
Sponsors and Cosponsors of S 3489
Latest Bills
Protecting Families from AI Data Center Energy Costs Act
Bill HR 6529August 1, 2026
Prices on the Wall Act of 2026
Bill HR 9390August 1, 2026
Pipeline Safety Authorization Act of 2026
Bill HR 9338August 1, 2026
Ratepayer Protection Act
Bill HR 9340August 1, 2026
Tyler’s Law
Bill HR 2004August 1, 2026
Stop Pills That Kill Act
Bill HR 8005August 1, 2026
Load Forecasting Enhancement Act
Bill HR 9332August 1, 2026
EMRTAI Authorization Act of 2026
Bill HR 9616August 1, 2026
High-Capacity Grid Act
Bill HR 6633August 1, 2026
Combating Illicit Xylazine Act
Bill HR 1266August 1, 2026

